Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Candel Therapeutics (CADL)
NASDAQ:CADL
Candel Therapeutics (CADL) Stock Price & Analysis
34 Followers
CADL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.15 - $4.25
Previous Close$1.53
Volume8.74K
Average Volume (3M)30.62K
Market Cap
$44.25M
Enterprise Value$7.78M
Total Cash (Recent Filing)$59.26M
Total Debt (Recent Filing)$22.79M
Price to Earnings (P/E)-1.7
Beta1.31
Next Earnings
Sep 06, 2023EPS Estimate
-$0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.92
Shares Outstanding28,919,810
10 Day Avg. Volume15,518
30 Day Avg. Volume30,622
Standard Deviation0.23
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)1.47
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue112.73
Enterprise Value/Gross Profit77.78
Enterprise Value/Ebitda-0.24
Forecast
1Y Price Target
$8.00Price Target Upside422.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Candel Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CADL FAQ
What was Candel Therapeutics’s price range in the past 12 months?
Candel Therapeutics lowest stock price was $1.15 and its highest was $4.25 in the past 12 months.
What is Candel Therapeutics’s market cap?
Currently, no data Available
When is Candel Therapeutics’s upcoming earnings report date?
Candel Therapeutics’s upcoming earnings report date is Sep 06, 2023 which is in 94 days.
How were Candel Therapeutics’s earnings last quarter?
Candel Therapeutics released its earnings results on May 11, 2023. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.35 by $0.05.
Is Candel Therapeutics overvalued?
According to Wall Street analysts Candel Therapeutics’s price is currently Undervalued.
Does Candel Therapeutics pay dividends?
Candel Therapeutics does not currently pay dividends.
What is Candel Therapeutics’s EPS estimate?
Candel Therapeutics’s EPS estimate is -$0.3.
How many shares outstanding does Candel Therapeutics have?
Candel Therapeutics has 28,919,810 shares outstanding.
What happened to Candel Therapeutics’s price movement after its last earnings report?
Candel Therapeutics reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.35. Following the earnings report the stock price went down -3.371%.
Which hedge fund is a major shareholder of Candel Therapeutics?
Among the largest hedge funds holding Candel Therapeutics’s share is Woodline Partners LP. It holds Candel Therapeutics’s shares valued at N/A.
---
Candel Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.00 (422.88% Upside)
$8.00 (422.88% Upside)
Hedge Fund Trend
Decreased
By 100.0K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.08%
12-Months-Change
Fundamentals
Return on Equity
-51.67%
Trailing 12-Months
Asset Growth
-33.80%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Candel Therapeutics
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
---
Top 5 ETFs holding CADL
Vanguard Total Stock Market ETF
$348.17K
Up to five ETFs with an Outperform Smart Score that hold CADL. The ETFs are listed according to market value of CADL within the ETF
---
---